News orgs that let pharma make claims before releasing data

This may be a trend. And if so, it's a troubling one.

On HealthNewsReview.org, we've just posted a review of a Wall Street Journal story that we characterize as
"Another story that lets a drug company get away with making superiority claims without releasing data."

Many news orgs let the makers of Provenge get away with this just a few days ago.

Stock manipulation anyone?

Is it going to kill anyone to wait until the data is actually released when independent expert opinion can be sought?

We don't like this practice one bit.

Read how the the European Court of Justice views journalism that it equates with advertising.


About this Entry

This page contains a single entry by Gary Schwitzer published on May 15, 2009 3:30 PM.

More vested interest vilification of virtual colonscopy decision was the previous entry in this blog.

HealthBusinessBlog: "I don't know what USA Today is thinking." is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Archives

Pages

Wikio - Top of the Blogs - Health

Add to Technorati Favorites